Jaclyn Martin

Jaclyn Martin is an accomplished professional in market access and patient services, currently serving as VP at Intellia Therapeutics, Inc. since October 2024. Previously, Martin held a variety of leadership roles at Bayer, including Vice President and Global Head of Market Access for Cell & Gene Therapy, where expertise was demonstrated in managing account relationships and launching new products, notably for oncology and rare diseases. Experience also includes pivotal positions at Dendreon and Amgen, focusing on market access marketing and payer marketing strategies. Martin began a career in healthcare consulting at Deloitte Consulting, serving key clients such as Aetna and Anthem. Jaclyn Martin holds an MBA in Marketing and General Management from Duke University's Fuqua School of Business and an MPH in Healthcare Management from Columbia University.